Abstract: Fullerenes can be formed into many new materials and devices. They have a wide range of applications in medicine, electronics, biomaterials, and energy production. An overview of the nanostructure and the physical and chemical characteristics of fullerene-drug derivatives is given. The biological behavior of fullerene derivatives shows their potential to medical application fields because C 60 is rapidly absorbed by tissues and is excreted through urinary tract and enterons, which reveals low toxicity in vitro and in vivo studies. Nanomedicine has become one of the most promising areas of nanotechnology, while many have claimed its therapeutic use against cancer, human immunodeficiency virus (HIV), and neurodegenerative disorders. Water-soluble C 60 fullerene derivatives that come from chemical modification largely enhance the biological efficacy. The blood-brain barrier (BBB) is a physical barrier composed of endothelial tight junctions that restrict the paracellular permeability. A major challenge facing neuropharmacology is to find compounds that can be delivered into the brain through the bloodstream. Fullerene C 60 was demonstratively able to cross the BBB by hybridizing a biologically active moiety dyad, which provides a promising clue as a pharmacological therapy of neural disorders.
INTRODUCTION
A fullerene is a molecule composed entirely of carbon in the form of a tube, a hollow sphere, or an ellipsoid [1] . The first fullerene was discovered in 1985 by Sir Harold W. Kroto, Richard E. Smalley, and Robert F. Curl Jr. In 1996, these three scientists were awarded the Nobel Prize for their pioneering efforts [2] . Prior to their discovery, only two welldefined allotropes of carbon were known: diamonds (composed of a three-dimensional crystalline array of carbon atoms) and graphite (composed of stacked sheets of twodimensional hexagonal arrays of carbon atoms). The fullerenes constitute a third form, and their existence eluded discovery until nearly the end of the 20 th century. The graphene also consists of sp 2 -bonded carbon atoms having potential for various biomedical applications [3] [4] [5] .
CHEMISTRY
Each molecule of the fullerene family (C n ) consists of 12 pentagons and m hexagons. C 60 fullerene consists of rigid carbon spheres with a radius of 0.498 nm Fig. (1) . It has two vacant tetrahedral sites and one octahedral site per C 60 molecule. These sites are of sufficient size to accommodate sphere radii of 0.112 and 0.206 nm, respectively. The van der Waals diameter of a C 60 molecule is approximately 1.1 nm [6] .
Single-wall nanotubes and C 60 fullerenes have diameters on the order of 1 nm, approximately half the diameter of an average DNA helix. The development of versatile functionalization chemistry allowed for a large variety of organic reactions to be carried out with fullerene, such as arylation, halogenation, hydroxylation, alkoxylation, and osmylation [7, 8] . CNTs have also gained increasing interest among polymer chemists as building blocks for constructing novel materials with interesting properties [8] . A number of metal-intercalated complexes are known, and fullerenes show a pronounced tendency to crystallize with solvent molecules trapped in the lattice to form host-guest complexes, such as [C 60 (g-cyclodextrin) 2 ] and [C 60 (1,4-hydroquinone) 3 ]. They are also able to form chargetransfer complexes with, for example, bis(ethylenedithio) tetra-thiafulvene. Fullerenes pass through addition reactions with various types of reagents forming oxygen, carbon, nitrogen, and metallic bridges. Addition may take place across either the 6,6-ring junction or the 5,6-ring junction, with the rings being either open fulleroid or closed fullerene structures [1] .
Macromolecular fullerene derivatives combine the unusual properties of fullerenes with the specific properties of many polymers. The first attempts to produce 'side-chain' polymers of C 60 included the use of diphenyl fulleroid as a building block [9] . Liu et al., [10] prepared C 60 -polystyrene polymers using Friedel-Crafts reactions, which include alkylation and acylation reactions. Geckeler and Hirsch [11] prepared C 60 -on-chain polymers by titrating toluene solutions of C 60 with the aminopolymers, poly(ethylenimine), and poly (4- 
methyl]styrene). Fullerene-based polymers, which were soluble in hexane or tetrahydrofuran (THF), were prepared by covalently attaching fullerenes to amine-containing hydrocarbon polymers. Fullerene alone is essentially insoluble in these solvents [12] ( Table 1) . Fullerenes are also insoluble in water but sparingly soluble in many solvents. Common solvents for fullerenes include aromatics, such as toluene, bromoform, benzene, and others solvents such as carbon disulfide, carbon tetrachloride and chloroform. Fullerenes are the only known allotrope of carbon that disolve in solvents at room temperature [13] [14] . Water-soluble C 60 fullerene derivatives were carefully studied because of the broad range of biological activities these compounds possess. The size, geometry, and surface characteristics of these structures make them appealing for use as drug carriers. Sun et al., [15] synthesized and characterized a water-soluble C 60 fullerene-poly (propionylethylenimine-co-ethylene) polymer.
TOXICITY
Mice tolerated a dose of 5000 mg/kg of body weight, and no evidence of toxicity was found in vivo for C 60 after intraperitoneal administration of large doses (Moussa et al., 1996 (Moussa et al., , 1997 [16, 17] . Mori et al., (2006) [18] did not find toxicity in rodents with C 60 and C 70 mixtures after oral administration of a dose of 2000 mg/kg body weight. Moreover, no evidence of genotoxic or mutagenic potential was observed in vitro. Gharbi et al., (2005) [19] http://en.wikipedia.org/wiki/Fullerene -cite_note-46 suggested that aqueous C 60 suspensions, which failed to produce acute or subacute toxicity in rodents, might protect their livers against free-radical damage in a dose-dependent manner. In 2007, Kolosnjaj et al., [20] [21] produced a comprehensive review of fullerene toxicity. These authors reviewed work on fullerene toxicity since the 1990s and concluded that little evidence gathered since the discovery of fullerenes indicated that C 60 is toxic. However, the extreme hydrophobicity and potential toxicity of fullerene limits its application as a therapeutic antioxidant [22] . Charge-transfer complexes
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With aminopolymers [11] , poly(ethylenimine) [11] and poly(4-[[(2-aminoethyl)imino]methyl]styrene) [11] Covalent attaching Amine-containing hydrocarbon polymers [12] Water-soluble Fullerene-poly(propionyl-ethylenimine-coethylene) [15] GENERAL APPLICATIONS Time-of-flight secondary ion mass spectrometry (TOF-SIMS) is a powerful tool in surface science and analysis. Fletcher et al., [23] found C 60 increased the sputter yield and secondary ions when used as a primary particle in SIMS analysis. They also investigated depth profiling of organic samples when using C 60 . No increase in damage was evident in the mass spectra when the impact energy was increased. A solid-phase extraction of the stationary phase with silica particles of different porosities was modified with an aminopropyl linker and then covalently bound to C 60 -fullerenoacetic acid or C 60 -epoxyfullerenes. The materials were successfully applied as an alternative to commercially available reversedphase materials for solid-phase extraction. These novel materials were applied for the desalting and preconcentration of proteins, peptides, and, especially, phosphopeptides. In addition, C 60 -fullerene silica, with a recovery rate of 99%, was applied for the solid-phase extraction of selected flavonoids [24] . Chiral porphyrin-fullerene dyads were produced for their potential use in photovoltaics [25] . A novel oligo(pphenylenevinylene) (OPV)-fullerene dyad, with strong intermolecular pi-pi interactions between the donor groups led to improvements in the fill factor and power conversion efficiency of dyad-based solar cells of up to 0.44% and 1.28%, respectively. These are the highest values reported for dyadbased solar cells so far [26] . Furthermore, in a 2010 report, the Norwegian Scientific Committee for Food Safety evaluated the application for the use of fullerene C 60 as a food additive.
MEDICAL APPLICATIONS C 60 Derivatives
Nanomedicine has become one of the most promising areas of nanotechnology. Current problems in nanomedicine involve understanding the toxicity and environmental impacts of nanoscale materials. Researchers in the conjectural field of molecular nanotechnology believe that cell repair machines could revolutionize medicine [27] . The biological behavior of fullerene derivatives shows their potential applications to various medical fields. Fullerenes are promising carriers of bioactive molecules and demonstrate increased circulation time and acceptable functionality [28] . Kirpatrick et al., (2011) [29] complexed fullerene compositions with multiple bioactive agents. C 60 is rapidly absorbed by tissues, especially by the coronal bone, breastbone, backbone, extremity honeycomb, liver, and spleen. Clearance was slow from all tissues except the brain. The compound is possibly excreted through urinary tract and enterons [30] . A method of treating free radical-related medical condition by using water-soluble fullerene derivatives had been developed. The method included the step of administering to a subject in need of such treatment an effective amount of a compound of the formula F(-X)m wherein F is a fullerene core; each X is independently OH, (CH 2 )n-SO 3 H, or a metal salt of (CH 2 )n-SO 3 - [31] . Some studies were carried out on the biological efficacy of water-soluble fullerenes in vitro [32] [33] and in vivo [34] [35] . The results revealed low toxicity. The administration of an aqueous solution of hydrated C 60 fullerenes (C 60 H y F n ), with a 30 nM concentration of C 60 as drinking water during chronic alcoholization of rats, protected tissues of the central nervous system from damage caused by oxidative stress and prevented the pathological loss of both astrocytes and astrocytic markers and glial fibrillary acidic proteins. Due to its adaptogenic effects, C 60 H y F n improved behavioral responses and eliminated emotional problems induced by chronic alcohol uptake. It also treated alcohol-induced encephalopathy and alcoholism prophylaxis (Table 2) [36] . A water-soluble nanoformulation of fullerene (C 60 ) was produced with a poly(N-vinyl pyrrolidine) (PVP) or poly(2-alkyl-2-oxazoline)s (POx) homopolymer and a random copolymer. Chung (2011) [37] developed a method for preparing a water-soluble fullerene derivative with excellent fluorescence by mixing a fullerene and a ligand containing a hydroxyl group which possesses bioaffinity, and thus can be useful in the biomedicine. Tong et al., [38] evaluated the cytotoxicity of these C 60 -polymer complexes, and the results demonstrated that C 60 -Pox complexes are non-toxic, neuronal cell-permeable, superoxide-scavenging antioxidants that might be candidates for treating brain-related diseases associated with increased levels of reactive oxygen species (ROS). A water-soluble compound of fullerene polycarboxylic anions was produced for inhibiting membrane viral infection [39] . The advancement of fullerene-specific antibodies using C 60 broadens the application of fullerenes as medicinal agents, diagnostic agents, imaging vectors, and drug delivery vehicles. The derivatives in various tissues and/or cells of experimental animal models were examined to identify any therapeutic activities [40] .
Traditional oral and injection drug delivery methods are not efficient for certain therapies. The rate of drug diffusion and transport is highly dependent on the size of the medicine. Typically, the skin cell membrane, made of phospholipids, cholesterol and lipoproteins plays an active role in controlling the ion transport into, out of and across the channels or ion pores using active energy against the concentration gradient. The small size of C 60 nanoparticles, can keep the bound drug molecules safe while passing across the membrane and can later release them to a suitable pH to act at the tissue target site [28] . The mechanisms used to achieve alternative routes for drug delivery typically unite one or more biologic, polymer, silicon-based, and carbon-based materials as well as metals. The materials used for biologics are lipids, peptides, nucleic acids, polysaccharides, and viruses in the form of vesicles, nanotubes, rings, and nanoparticles. The materials for polymerics are poly(glycolic acid), poly(alkylcyanoacrylate), and poly(3-hydroxybutanoic acid) are in the form of vesicles, spheres, nanoparticles, and dendrimers. For silicon-(like silicones), carbon-(like carbon), or metallic-based (like silver, palladium, platinum and gold) materials, they are in the form of porous particles, nanoparticles, and nanoshells [41] . The advantages of nanostructuremediated drug delivery include the ability to directly deliver drug molecules into cells [42] , and the capacity to target tumors in healthy tissues [43] . Fullerenes have been studied for potential medicinal use. They bind specific antibiotics to their structures to target resistant bacteria and can even target certain cancer cells like melanomas. The October 2005 issue of Chemistry & Biology [44] contains an article explaining the use of fullerenes as light-activated antimicrobial agents. Fullerene derivatives were used as a carrier for serum protein profiling, which is a powerful tool used to distinguish protein signatures for pathologies and biomarker findings. This tool uses a material-enhanced laser desorption/ionization (MELDI) technique. MELDI is a new form of laser desorption/ionization that was introduced in 2005 by Bakry' laboratory [45] [46] [47] .
RADICAL SCAVENGING AND BLOOD BRAIN BAR-RIER (BBB) PENETRATION CHARACTERISTICS
The exceptional radical-scavenging property of fullerene makes it a favorable pharmacophore that can be used to target and counterbalance cellular harm caused by the overexpression of radicals [33, [48] [49] [50] . This radical-scavenging characteristic was shown to protect cell growth from various toxins that can cause apoptotic injuries in vitro [51] [52] [53] to neuronal [33, 54] , hepatoma [55] , and epithelial cells [56] .
The blood-brain barrier (BBB) is a physical barrier composed of endothelial tight junctions that restrict the paracellular permeability. The barrier is formed by capillary endothelial cells surrounded by basal lamina and astrocytic perivascular endfeet Fig. (2) . The functional intricacy of these membranes is attributed mainly to brain microvessel endothelial cells and the manifestation of complex tight junctions between the endothelial cells of the BBB [57] [58] [59] . Efflux transport systems consisting of energy-dependent membrane protein may target the drugs and export them from the brain [57, 60] . The BBB, therefore, acts as an obstacle for the systemic delivery of neurotherapeutics. To cross the BBB, a central nervous system (CNS) drug should be relatively small and hydrophobic to mix well with membrane layers and un-charged at blood pH. One nano-enabled drug delivery Fullerene polycarboxylic anions Inhibit membrane viral infection [39] Fullerene-specific antibodies [40] Apply as medicinal agents, diagnostic agents, imaging vectors, drug delivery vehicles Nanostructure-mediated drug Deliver drug molecules directly into cells [42] Target tumors [43] Binding specific antibiotics [44] Target resistant bacteria
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Polysorbate 80-coated Produce endocytosis followed by possible transcytosis [72] Deliver drugs to the brain [73] Doxorubic bound Treat glioblastoma [74] Fullerene core and glutamate receptor ligand residues Neuroprotective agents [79] Fulleropyrrolidine-thalidomide dyad [80] Suppress the release of nitric oxide (NO) and tumor necrosis factor (TNF)- Synthetically modified fullerene Treat inflammatory disorders or inhibit the build-up of arterial plaque [84] system used for the in vivo administration of drugs targeting the brain is a rapidly biodegradable poly(butylcyanoacrylate) (PBCA) nanoparticle. PBCA nanoparticles coated with polysorbate 80 are thought to cross the BBB via plasma adsorption of apolipoproteins, which results in a receptormediated endocytosis by brain capillary endothelial cells as apolipoproteins cross the BBB [61] . Fullerene molecules rapidly accumulate in water but disaggregate after entering the membrane interior. The compound was also able to cross the BBB [34, 49] . The apoptosis of cerebral microvessel endothelial cells (CMECs) induced by oxidative stress injury plays a key role in the dysfunction of the BBB. Using CMECs as an in vitro BBB model, Lao et al., (2009) [62] demonstrated that C 60 (C(COOH) 2 ) 2 nanoparticles can selectively enter oxidized CMECs rather than normal cells, and then protect them from apoptosis [63] .
PHOTODYNAMIC THERAPY (PDT)
Another potential medical application of C 60 is associated with the photoexcitation of fullerenes. An excited fullerene can be reduced under biological conditions in the presence of biological reducing agents, such as guanosine. In addition, singlet oxygen and superoxide radical anions are renowned reactive species towards DNA [64] . This property of fullerenes makes them potential photosensitizers for use in PDT. The cytotoxicities of a dendritic C 60 monoadduct and malonic acid C 60 trisadduct were investigated on Jurkat cells, and upon exposure to UV light, the cell number was found to descend by approximately 19% within 2 weeks [65] . The photodynamic activities of fullerenes derivatized with hydrophilic and cationic groups against a range of mouse cancer cell lines were studied. Monocationic fullerene was found to be a highly effective photosensitizer for killing cancer cells by the rapid induction of apoptosis after illumination [65] . 
HIV INHIBITION
Several antiviral compounds can suppress the replication of the HIV. These are effective in preventing or detaining the commencement of acquired immunodeficiency syndrome (AIDS). Fullerenes (C 60 ) and their derivatives have promising antiviral activity, and this has strong implications for the treatment of HIV infection [47] . Fullerene derivatives can inhibit and form complexes with HIV protease (HIV-P) [66] [67] . Amino acid derivatives of fullerene C 60 (ADFs) were found to inhibit HIV and human cytomegalovirus replication [68] . "Cationic-, anionic-, and amino acid-type fullerene derivatives inhibit HIV-reverse transcriptase and hepatitis C virus replication. Anionic fullerene derivatives present antioxidant properties, whereas cationic derivatives have antibacterial and antiproliferative activities. Amino acid-type derivatives were found to be the most active of all the fullerene derivatives [47, 69] ."
FULLERENE DYAD FOR NEURODEGENERATIVE DISEASES
Many nanostructures, including polymeric nanoparticles, polymeric nanospheres and nanosuspensions, polymeric nanogels, carbon nanotubes and nanofibers, polymeric nanomicelles, and polymeric nano-liposomes, have been applied to the development of nano-enabled drug delivery systems to treat neurodegenerative disorders [57] . Polymeric nanoparticles were used for the delivery of several drugs to the central nervous system (CNS). Compositions comprising C 60 fullerene for ameliorating, treating and reversing CNS disorder has been developed [70] . Calvo (2001) [71] PEGylated long-circulating PHDCA nanoparticles and found they could penetrate into the brain to a larger extent than all the other tested formulations. The results given in Alyaudtin (2001) [72] , supported the hypothesis that the mechanism of bloodbrain barrier transport of drugs by polysorbate 80-coated nanoparticles was one of endocytosis followed by possible transcytosis. At concentrations of PBCA nanoparticles and polysorbate-80 that achieved significant drug delivery to the brain, specific mechanisms of delivery to the CNS rather than a simple disruption of the BBB, which allowed a diffusional drug entry, is suggested [73] . A doxorubicin bound to nanoparticle study showed that the therapy offered a therapeutic potential for the treatment of human glioblastoma [74] . Nanogel is a hydrophilic nanosized carrier based on a crosslinked network of branched polyethylenimine (PEI) and poly(ethylene glycol) (PEG) molecules. It was demonstrated as a drug delivery system to combine molecules such as oligonucleotides, small-interfering RNA, DNA, proteins, and low-molecular-mass drugs [75] . Polymeric nano-micelles have a coreshell architecture with a hydrophobic core and a shell of hydrophilic polymer blocks. The shell stabilizes the nano-micelles and covers the drug from interactions with serum proteins and untargeted cells. Polymeric nanomicelles are versatile and have been shown to deliver DNA molecules efficiently in vitro and in vivo, although no study on their successful delivery to the CNS has been reported [76] [77] [78] . A fullerene core and glutamate receptor ligand residues were also used as neuroprotective agents [79] . The C 60 fulleropyrrolidine-thalidomide dyad (CLT) is an effective agent for suppressing the release of nitric oxide (NO) and tumor necrosis factor (TNF)-by lipopolysaccharide (LPS)-stimulated RAW264.7 macrophages [80] . The fulleropyrrolidine-xanthine dyad Fig. (3) can effectively suppress LPSinduced NO production [81] . These water-soluble C 60 -fullerene-xanthine dyads aggregate in water, producing an average nanoscale dimension of approximately 78.9 nm in diameter. Huang et al., [80] [81] have prepared and explored the usability of novel water-soluble fullerenes which can endure variety of known anti-inflammatory agents Fig. (4) . The concept of C 60 hybridizing a biologically active moiety dyad that utilizes a synergistic effect is consistent with our previous report that the C 60 fulleropyrrolidine moiety with the xanthine moiety is more efficient in suppressing inflammation in LPS-stimulated macrophages than is the fulleropyrrolidine moiety alone. A C 60 fullerene derivative incorporating poly(ethylene glycol) (PEG), PEG-C 60 -3, reducedamyloid (A ) [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] -induced cytotoxicity and increased cell viability in cells co-treated with C 60 and A [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] . Moreover, intracellular ROS accumulation caused by A -treated Neuro-2A cells was reduced by PEG-C 60 -3 co-treatment. A treated cells triggered the signaling cell cycle, which stimulated repair and protected cells from apoptosis through changes in gene expression. Microarray analysis elucidated the cytoprotective effect of PEG-C 60 -3 that might result from intracellular oxidative stress alleviation, ion-channel and transporter homeostasis, cell cycle regulation, and modulation in transcription factor activity, thus, protecting the cell from apoptosis [82] . Lee et al., [83] further discovered the use of the dyads, PEG-C 60 -3 (incorporating PEG) and PTX-C 60 -2, as novel agents to fight neurodegenerative diseases. They found that cytoprotection by PEG-C 60 -3 and PTX-C 60 -2 was partially lessened by an autophagy inhibitor, showing that the elicited autophagy and antioxidative activities protected cells from A damage. PTX-C 60 -2 was more effective than PEGC 60 -3 at sustaining the induced autophagy. They believe fulleropyrrolidine moiety in PTX-C 60 -2 acting as an antioxidant is not the sole molecular mechanism of these compounds for rescuing cells from A -induced cell cytotoxicity. An agent combining antioxidative activities with the ability to cross the BBB would be expected to have great synergy in medicinal applications in combating brain diseases. Moreover, Kepley (2011) [84] invented methods for treating inflammatory disorders or for inhibiting the build-up of arterial plaque by applying a therapeutically effective amount of a synthetically modified fullerene. These results suggest the promising use of C 60 fullerene or fullerene dyads as drug treatment to support the pharmacological and nonpharmacological therapy of neurodegenerative diseases.
Graphene is the structural element of fullerenes that consists a single-or few-layered sheet of Sp2-bonded carbon atoms. The non-porous carbon materials wherein the carbon material has a smallest dimension of less than 100 nanometers are employed for medical use. In preferred aspects, the material is topically used on wounds, orally administered as sorbent for various toxins, or employed as a sorbent in hemodialysis [85] . This 2D nanomaterial was reported compatible with blood [86] , thus the graphene-based drug loading and delivery systems were explored and ultra-high drug loading efficiency was achieved owing to its extremely large surface area. Even there are some unresolved issues and challenges in graphene-based nanomedicine, the unique physical and chemical properties of graphene, are intensively discussed for its novel applications in biological sensing, cancer therapies and potentially biomedical imaging [5] .
CURRENT AND FUTURE DEVELOPMENTS
A major challenge facing neuropharmacology is to find compounds that can be delivered into the brain through the bloodstream. Fig. (2) shows the molecular traffic across the BBB. The large surface area of the lipid membranes of the endothelium offers an effective diffusive route for lipidsoluble agents. Versatile functionalization chemistry has been developed and various of organic reactions have been carried out with relatively small nanoscale fullerenes. Fullerene is an excellent nanocarrier for hydrophobic molecule delivery and an effective neuroprotective antioxidant. These nanoparticles possess the novel ability of selectively entering oxidation-damaged cerebral endothelial cells, rather than normal endothelial cells, and then protecting them from apoptosis. Fullerene, C 60 , and C 60 -drugs may answer to the special needs of modern medications. These, along with the low toxicity detected in fullerene, are sufficient to stimulate researchers to unite their efforts. Moreover, the direct application of fullerenes and their derivatives to neurodegenerative disorders is promising.
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